Novel amino-β-lactam derivatives as potent cholesterol absorption inhibitors
Open Access
- 1 November 2014
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 87, 722-734
Abstract
No abstract availableKeywords
Funding Information
- Croatian Ministry of Science, Education and Sports
- Austrian Science Fund FWF (DK-MCD W1226, SFB LIPOTOX F30, P22832)
- Croatian-Austrian Intergovernmental S&T Cooperation Programme (HR 08/12)
This publication has 32 references indexed in Scilit:
- Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United NationsInternational Journal of Cardiology, 2013
- Adipose triglyceride lipase is a TG hydrolase of the small intestine and regulates intestinal PPARα signalingJournal of Lipid Research, 2013
- Ezetimibe blocks the internalization of NPC1L1 and cholesterol in mouse small intestineJournal of Lipid Research, 2012
- Comparative efficacy of the addition of ezetimibe to statinvsstatin titration in patients with hypercholesterolaemia: systematic review and meta-analysisCurrent Medical Research and Opinion, 2011
- Conformational Analysis of β‐Lactam‐Containing Ferrocene PeptidesEuropean Journal of Inorganic Chemistry, 2009
- Madin-Darby Canine Kidney II Cells: A Pharmacologically Validated System for NPC1L1-Mediated Cholesterol UptakeMolecular Pharmacology, 2008
- A short history of SHELXActa Crystallographica Section A Foundations of Crystallography, 2007
- Heterocyclic ring scaffolds as small-molecule cholesterol absorption inhibitorsOrganic & Biomolecular Chemistry, 2005
- Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol AbsorptionScience, 2004
- Synthesis of C3 Heteroatom-Substituted Azetidinones That Display Potent Cholesterol Absorption Inhibitory ActivityJournal of Medicinal Chemistry, 1998